# FDA recall D-128-2013

> **Teva Pharmaceuticals USA, Inc.** · Class III · drug recall initiated 2012-04-24.

## Product

CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88

## Reason for recall

Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life

## Distribution

Nationwide

## Key facts

- **Recall number:** D-128-2013
- **Recalling firm:** Teva Pharmaceuticals USA, Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2012-04-24
- **Report date:** 2013-01-23
- **Termination date:** 2013-12-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Sellersville, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-128-2013

## Citation

> AI Analytics. FDA recall D-128-2013. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-128-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*